New ALS drug stabilizes decline with improved strength, mobility for some
Long-term use of a new drug, toferson, approved by the FDA for a rare genetic form of ALS, delays symptom progression and death and leads to stabilization or improvement in some patients, according to a study by WashU Medicine researchers and collaborators.
Mapping the dance of circadian synchrony
Researchers at Washington University in St. Louis have found a way to better track circadian brain signals that synchronize the body clocks.
Defying gravity
The remarkable journey of WashU student Jordan Hughes, who matriculated on campus against all odds.